Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tandem Diabetes Care

20.59
-0.9600-4.45%
Volume:275.06K
Turnover:5.75M
Market Cap:1.37B
PE:-7.36
High:21.42
Open:21.39
Low:20.47
Close:21.55
Loading ...

Diabetes Device Makers' Shares Down After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial

THOMSON REUTERS
·
17 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Plug Power, Snap-On

Reuters
·
17 Apr

Reasons to Hold TNDM Stock in Your Portfolio for Now

Zacks
·
17 Apr

BUZZ-Diabetes device makers fall after data on Lilly's weight loss pill

Reuters
·
17 Apr

Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs

GuruFocus.com
·
17 Apr

RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating

MT Newswires Live
·
15 Apr

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

StockStory
·
15 Apr

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

Zacks
·
15 Apr

3 Undervalued Small Caps With Recent Insider Activity Across Regions

Simply Wall St.
·
11 Apr

Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?

Zacks
·
10 Apr

Mizuho Initiates Tandem Diabetes Care at Neutral With $20 Price Target

MT Newswires Live
·
10 Apr

Tandem Diabetes Care Initiated at Neutral by Mizuho

Dow Jones
·
10 Apr

Hold Rating for Tandem Diabetes Care Amid Competitive and Macroeconomic Challenges

TIPRANKS
·
10 Apr

Tandem Diabetes Care (TNDM) Gets a Buy from Lake Street

TIPRANKS
·
07 Apr

BRIEF-Tandem Diabetes Care To Announce First Quarter 2025 Financial Results

Reuters
·
04 Apr

Press Release: Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

Dow Jones
·
04 Apr

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

THOMSON REUTERS
·
04 Apr

Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

Zacks
·
28 Mar

Tandem Diabetes Care Insiders Sell US$1.5m Of Stock, Possibly Signalling Caution

Simply Wall St.
·
28 Mar

Stifel Nicolaus Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)

TIPRANKS
·
24 Mar